News Menu

no image

Join us on a journey from curiosity to discovery and innovation. See how decades of diligence and a measured approach led CSHL Professor Lloyd Trotman from the first natural model of metastatic prostate cancer to a potential new therapy, set to begin clinical trials next year. Also in this issue, we dive into CSHL’s fascinating research on aging and senescence, which stands to fundamentally redefine the burgeoning field of longevity science. Download the full issue now and follow the links below for special bonus content, including a profile of CSHL’s Corina Amor Vegas and videos from the 89th CSHL Symposium.

Features

READ THIS ISSUE

Bonus Content